Last checked at 30 Jan 2015 09:39
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Bowleven Share News (BLVN)
BLVN Share
Price
BLVN Share
News
BLVN Share
Chat
BLVN Share
Trades
BLVN
Live RNS
BLVN Share
Charts
BLVN Level 2
Console
BLVN Live
Share Price
BLVN Broker
Ratings
BLVN Directors
Deals
BLVN Financial
Diary
BLVN
Fundamentals
BLVN Short
Positions
BLVN
Media
Bowleven Information
Share Price Information for Bowleven (BLVN)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
0.20
Bid:
0.15
Ask:
0.25
Change:
0.00 (0.00%)
Spread:
0.10 (66.667%)
Open:
0.20
High:
0.20
Low:
0.20
Prev. Close:
0.20
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.Bowleven sweats on Cameroon presidential signature
Tue, 23rd Dec 2014 07:42
Cameroon-focused oil explorer Bowleven has allowed extra time for the completion of the farm-out agreement over its Etinde project as it continued to sweat over presidential approval.Having in October said the only remaining formality to the completion of the transaction was the gazetting of the signed Presidential decree, the Aim-listed company has revealed that the presidential signature remained un-inked but was "imminent".As such, while Bowleven's management acknowledged that the formal gazetting of the decree "remains achievable" by 31 December 2014, the company and the potential farm-out partners Lukoil/Newage have agreed to an extension to the longstop date to 28 February 2015 to allow additional time if required.The company noted that the Etinde exploration production sharing contract (PSC) which covers the Etinde permit acreage not included within the Etinde Exploitation Authorisation (EEA) awarded in July 2014, formally expired on 22 December 2014.Bowleven has applied for a new PSC over this area and discussions to retain this acreage are underway with the Cameroon authorities, it said.Current Etinde development plans are focused on the 461km-square area covered by the EEA which gives exploitation and development rights for an initial period of 20 years.
More News
23 Dec 2014 16:51
London close: Santa Rally continues as UK stocks rise for sixth straight day
UK stocks rose again on Tuesday as the Santa Rally continued into its sixth straight day, with markets boosted by some upbeat economic data from the States. Third-quarter US annualised gross domestic product (GDP) growth was revised to 5% from an initial estimate of 3.9%, representing the strongest
Read more23 Dec 2014 11:56
London midday: Stocks rise but gains pared after UK GDP data
UK stocks rose again on Tuesday as the pre-Christmas rally continued, though gains were trimmed by lunchtime after some disappointing data. On a day lacking of corporate news, investors were also showing caution ahead of a flurry of economic indicators Stateside. Stock futures on Wall Street were on
Read more24 Nov 2014 06:33
Monday newspaper round-up: Aviva, Iran, AIM
An estimated 2,000 insurance jobs are likely to be axed as Aviva tries to placate scepticism about its bid for Friends Life. While some analysts hailed the £5.6bn deal announced on Friday evening as giving Aviva scope to push up its dividend, others were unimpressed, with one questioning whether it
Read more21 Nov 2014 11:06
Westhouse highlights attractive oil stocks that can weather crude-price falls
Westhouse Securities has called for investors in the oil and gas sector to be a "bit more patient" with oil prices currently rumbling along at multi-year lows, as it highlighted buying opportunities in the sector. Brent crude has now fallen over 25% to $79 a barrel since hitting a high of $115 a bar
Read more13 Nov 2014 10:21
Thursday broker round-up.-Update
AstraZeneca: JP Morgan raises target price from 3700p to 4100p, keeping its underweight rating. AVEVA Group: Barclays upgrades to overweight. Bellway: Credit Suisse raises target price from 1876p to 1905p and keeps a neutral rating. Bow Leven: Barclays shifts target price from 45p to 50p and retai
Read more13 Nov 2014 06:14
12 Nov 2014 16:04
12 Nov 2014 06:22
11 Nov 2014 16:20